We designed and successfully synthesized novel nucleic acid analogues with a C3'-C4' trans-fused sixmembered ring, Irans-3',4'-BNAs from D-glucose. A H-NMR experiment and X-ray crystallographic analysis demonstrated that the sugar puckering of trans-3',4'-BNA was restricted in an S-type conformation. We also achieved its incorporation into oligonucleotides using automated DNA synthesizer.
INTRODUCTION
Double-stranded RNA and DNA are well known to preferentially form A-and B-type helical structures, respectively. The A-type helix has a fixed N-type sugar conformation in each nucleotide unit, while the B-type one possesses a rigid S-type sugar moiety (Fig. la) .
Recently, restricting a sugar puckering into the suitable conformation has become a most promising approach to develop the oligonucleotides strongly interacting with complementary RNA and DNA. In the last few years, we and other groups have synthesized novel nucleoside analogues with a fixed N-type sugar conformation and
1: X = OMe; Y = H 6: X = H; Y = OMe demonstrated the oligonucleotides containing these analogues have strong affinity with natural nucleic acid complements.' On the other hand, some nucleoside analogues restricted in an S-type conformation have also been reported.2 However, slightly decreasing affinities towards natural oligonucleotides were observed, probably due to insufficient restriction of the sugar conformation or steric repulsion between the additional ring and neighboring nucleotide residues.
To solve these problems, we designed a novel nucleic acid analogue with an S-type conformation, truns-3',4'-BNA 1, which has a C3'-C4' trans-fused six-membered ring. The additional ring was expected to locate outside the B-type DNA duplexes and to avoid the steric repulsion. In this report, we describe the synthesis of the trans-3',4'-BNAs and their incorporation into oligonucleotides ( 
RESULTS AND DISCUSSION
As shown in Scheme 1, trans-3',4'-BNA 1 was successfully synthesized from the known D-allofuranose derivative 2, which was easily converted from D-glucose in four steps. Introduction of a hydroxymethyl group at the C4 position of 2 proceeded by the conventional aldolCanizzaro reaction to give the diol product in 65% yield (three steps). The 5-hydroxy group was selectively protected with the benzyl group, and then a ptoluenesulfonyl group was introduced into the other hydroxyl group. The obtained product was treated with Os04 and Na1O4 followed by reduction with NaBH4 to give the primary alcohol product in 23% yield (four steps). The given product was treated with Ac20, AcOH and a catalytic amount of conc. H2S04 to afford the glycosyl donor 3 in 98% yield. Coupling reaction of 3 with silylated thymine followed by conversion of the two acetyl groups gave the primary alcohol 4 in 56% overall yield. Ringclosure reaction successfully proceeded on treatment with NaHMDS, and deprotection of the 2'-hydroxyl group with p-toluenesulfonic acid afforded 5 in 62% yield (two steps). The thymine nucleobase of 5 was protected with a benzyloxymethyl (BOM) group. The obtained compound was treated with NaH and Me1 followed by deprotection of both 3'-0-and 5'-O-benzyl groups and the BOM group at the nucleobase to afford the desired trans-3 ',4'-BNA monomer 1 in 30% overall yield. The sugar puckering of 1 was found to be restricted to an S-type (c3'-exo) conformation by means of 'H-NMR experiment and X-ray crystallographic analysis.
To incorporate the trans-3',4'-BNA monomer 1 into oligonucleotides, we attempted the conversion of 1 to a phosphoramidite derivative. However, the phosphitylation at the 3'-hydroxy group did not proceed efficiently, ; ii) NaI04; iii) 37% HCHO aq., 1M NaOH aq., 65% (three steps); iv) NaH, BnBr, 56%; v) TsCI, 80%; vi) OsO,, Na104; vii) NaBH,, 63% (two steps); vjji) AcOH, AGO, HZS04, 98%; ix) thymine, BSA, TMSOTf, 87%; c) I) MeNH2, 87%; ii) 2-methoxypropene, 85%; 2M NaOH aq., 87%; d) i) NaHMDS, 87%; ii) TsOH/H20, 87%; e) i) BOMCI, DBU, 90%; ii) NaH, MeI, 86%; iii) 20% Pd(OH)2-C, cyclohexene, 39%; f) i) Dess-Martin periodinane, 97%; ii) DIBAL-H, 67%; iii) BOMCI, DBU, 90%; iv) NaH, MeI, 86%; v) 20% Pd(OH)& HCOONH4, 94%; g) i) DMTrOTf, pyridine/CHzC12, 93%; ii) 2-cyanoethyl-N,N,N',N'tetraisopropylphosphorodiamidite, 4 3 -dicyanoimidazole, 46%; h) DNA synthesizer. Thy = Thymin-1-yl probably due to the steric hindrance of' the 2'-0-methyl group. Then we synthesized anather analogue, trans-3 ',4'-BNA arabino monomer 6, of which the 3'-hydroxyl group is less hindered than that of ribo-type analogue 1.
The 2'-hydroxyl group of 5 was oxidized with DessMartin reagent and then reduced with DIBAL-H to afford the corresponding arabino-type compound. After methylation of the 2'-hydroxyl group, both benzyl groups at the 3'-and 5'-positions were deprotected to give the desired trans-3',4'-urubino-BNA 6. Treatment of 6 with 4,4'-dimethoxytrityl triflate4 (DMTrOTf) was followed by phosphytilation with 2-cyanoethyl-N,N,N',N'-tetraisopropylphospholodiamidite and 4,5-dicyan~imidazole~ to give the amidite derivative 7. The incorporation of 7 into oligonucleotides was carried out by using an automated DNA synthesizer with some modified procedures. For efficient coupling, prolonged reaction time, elevated reaction temperature and use of tert-butylhydroperoxide as an oxidation reagent were required. The composition of the obtained oligonucleotide analogues was confirmed by MALDI-TOF-Mass spectra.
Futher studies on the properties of the oligonucleotieds containing trans-3',4'-BNAs and the synthesis of some other nucleoside analogues bearing a restricted S-type conformation (e.g. compound 8, Fig. 1 b) are in progress.
